Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Symbollon Pharmaceuticals (NasdaqSC:SYMBA)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Insider | Reports
Location
37 Loring Drive
Framingham, MA 01702
Phone: (508) 620-7676
Fax: (978) 443-0166
Employees (last reported count): 4
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Related Links
 ·Search Yahoo! for related links...
Ownership
·Insider and 5%+ Owners: 53%
·Institutional: 0% (0% of float)
(one institution)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Symbollon Pharmaceuticals, Inc., formerly known as Symbollon Corporation, is engaged in the development and commercialization of proprietary iodine-based pharmaceutical agents and antimicrobials. Iodine has been shown to be a rapid acting, broad-spectrum antimicrobial and an effective therapeutic for certain pharmaceutical applications. The therapeutic index of a drug is the ratio of the largest safe dose to the smallest effective dose. The Company's technology controls the ratio of molecular iodine (I2) to the other inactive species of iodine typically present in solution.
More from Market Guide: Expanded Business Description

Financial Summary
Symbollon Pharmaceuticals, Inc. researches, develops and commercializes proprietary iodine-based, pharmaceutical agents, disinfectants, antiseptics and sanitizers. For the six months ended 6/30/01, revenues rose 35% to $110 thousand. Net loss rose 38% to $734 thousand. Revenues reflect increased sales of IodoZyme. Higher loss reflects increased costs related to the development of Iogen and higher general and administrative expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Jack Kessler, Ph.D., 50
Chairman, CEO, Sec. and Chief Scientific Officer
$176K
Paul Desjourdy, 39
Pres, COO, Chief Financial Officer, Gen. Counsel, Treasurer, Director
170K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqSC:SYMBAAs of 31-Aug-2001
Price and Volume
52-Week Low
on 3-Jan-2001
$0.75 
Recent Price$3.90 
52-Week High
on 6-Sep-2000
$5.625
Beta0.94 
Daily Volume (3-month avg)3,409 
Daily Volume (10-day avg)1,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-17.9%
52-Week Change
relative to S&P500
+10.1%
Share-Related Items
Market Capitalization$16.7M
Shares Outstanding4.27M
Float2.00M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.70 
Earnings (ttm)-$0.16 
Earnings (mrq)-$0.10 
Sales (ttm)$0.19 
Cash (mrq)$0.68 
Valuation Ratios
Price/Book (mrq)5.54 
Price/EarningsN/A 
Price/Sales (ttm)20.52 
Income Statements
Sales (ttm)$780.0K
EBITDA (ttm)-$791.0K
Income available to common (ttm)-$669.0K
Profitability
Profit Margin (ttm)-85.8%
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-18.05%
Return on Equity (ttm)-20.65%
Financial Strength
Current Ratio (mrq)12.21 
Debt/Equity (mrq)0 
Total Cash (mrq)$2.82M
Short Interest
As of 8-Aug-2001
Shares Short0 
Shares Short
(Prior Month)
0 
Daily Volume3,000 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.